1-(4,5-Dichloro-2-hydroxyphenyl)ethan-1-one, 95%, 1g

1-(2-Fluorophenyl)-1H-imidazole-4-carboxylic acid, 250mg

1-(2-Methoxyethyl)hydrazine dihydrochloride, 95.0%, 1g

2-Bromopyridin-3-amine, 98.0%, 1g

5,6-Dihydroxy-4-oxo-2-phenyl-4H-1-benzopyran-7-yl ?-D-Glucopyranosiduronic Acid, 98.0%, 1g

5-Ethynyl-2,3-dihydro-1H-indene, 95%, 100mg

Neu5Ac alpha(2-6)Gal beta MP Glycoside>95.0%(HPLC)50mg

2-(3-Methoxy-phenyl)-benzofuran-5-carboxylic acid methyl ester, 95.0%, 1g

5-Ethyl-4,5,6,7-tetrahydro-thiazolo[5,4-c]pyridin-2-ylamine, 95.0%, 100mg

(S)-2-((tert-Butoxycarbonyl)amino)-3-(trityloxy)propanoic acid, 95+%, 100g

Methyl 2-[2-(trifluoromethyl)quinolin-4-ylthio]-acetate, 5g

4-Iodo-2,6-difluorotoluene, 95.0%, 5g

3-Hydroxy-4-methylbenzoic acid, min. 98%, for synthesis, 1 g, glass packaging